Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Return on Sales (2022 - 2023)

Unicycive Therapeutics filings provide 2 years of Return on Sales readings, the most recent being 0.3% for Q4 2023.

  • On a quarterly basis, Return on Sales changed N/A to 0.3% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.3%, a N/A change, with the full-year FY2023 number at 0.3%, down 11.0% from a year prior.
  • Return on Sales hit 0.3% in Q4 2023 for Unicycive Therapeutics, down from 0.29% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.06% in Q3 2022 to a low of 0.3% in Q4 2023.